https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54056 Wed 28 Feb 2024 15:08:10 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41921 p = 0.0007). Studies of other clinical decision support systems and heparin monitoring systems did not demonstrate improved safety, and quality findings were inconsistent. Systematic education and feedback programs were not efficacious. Conclusions: There is currently insufficient high-quality evidence to recommend any reviewed intervention, though several warrant closer evaluation. Adequately powered controlled trials assessing safety outcomes and evidence-based quality markers in high-risk patient groups and studies of interventions to improve safety of LMWH and DOAC prescribing are needed.]]> Tue 16 Aug 2022 09:02:13 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27289 Sat 24 Mar 2018 07:40:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47953 Mon 13 Feb 2023 14:06:54 AEDT ]]>